Noile-Immune Biotech (TSE:4893) Days Sales Outstanding : 0.00 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech Days Sales Outstanding?

Noile-Immune Biotech's average Accounts Receivable for the three months ended in Mar. 2024 was 円0.0 Mil. Noile-Immune Biotech's Revenue for the three months ended in Mar. 2024 was 円2.6 Mil. Hence, Noile-Immune Biotech's Days Sales Outstanding for the three months ended in Mar. 2024 was 0.00.

The historical rank and industry rank for Noile-Immune Biotech's Days Sales Outstanding or its related term are showing as below:

TSE:4893' s Days Sales Outstanding Range Over the Past 10 Years
Min: 12.55 Med: 12.77 Max: 386.92
Current: 386.92

During the past 4 years, Noile-Immune Biotech's highest Days Sales Outstanding was 386.92. The lowest was 12.55. And the median was 12.77.

TSE:4893's Days Sales Outstanding is ranked worse than
91.49% of 881 companies
in the Biotechnology industry
Industry Median: 72.66 vs TSE:4893: 386.92

Noile-Immune Biotech's Days Sales Outstanding stayed the same from Mar. 2023 (0.00) to Mar. 2024 (0.00).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Noile-Immune Biotech Days Sales Outstanding Historical Data

The historical data trend for Noile-Immune Biotech's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech Days Sales Outstanding Chart

Noile-Immune Biotech Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

12.99

12.55

Noile-Immune Biotech Quarterly Data
	Dec20	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial				-	-	99.45	11,261.22	-

Competitive Comparison of Noile-Immune Biotech's Days Sales Outstanding

For the Biotechnology subindustry, Noile-Immune Biotech's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Noile-Immune Biotech's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Noile-Immune Biotech's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Noile-Immune Biotech's Days Sales Outstanding falls into.

Noile-Immune Biotech Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Noile-Immune Biotech's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	316.818	*	365
=	0					/	316.818	*	365
=	0.00

Noile-Immune Biotech's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	2.587	*	365 / 4
=	0					/	2.587	*	365 / 4
=	0.00

Noile-Immune Biotech (TSE:4893) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Noile-Immune Biotech Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Noile-Immune Biotech's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Noile-Immune Biotech (TSE:4893) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012

Website

https://www.noile-immune.com

Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech (TSE:4893) Headlines

No Headlines